Transthyretin-directed RNA Interaction [EPC]

175 reported adverse events

Drugs of this class: EPLONTERSEN

These side effects are most commonly reported by patients taking drugs of the Transthyretin-directed RNA Interaction [EPC] class:

# Side effect Count
0 DEATH 16
1 FATIGUE 13
2 NAUSEA 13
3 NEUROPATHY PERIPHERAL 13
4 PAIN 9
5 PRODUCT DOSE OMISSION ISSUE 7
6 VOMITING 7
7 DIARRHOEA 6
8 HYPOAESTHESIA 6
9 PAIN IN EXTREMITY 6
See all common reactions for Transthyretin-directed RNA Interaction [EPC]

Drugs of the Transthyretin-directed RNA Interaction [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLUID RESUSCITATION 1 0.5000
1 MAGNETIC RESONANCE IMAGING HEAD 1 0.1111
2 PROSTATIC ARTERY EMBOLISATION 1 0.0625
3 ACQUIRED ATTR AMYLOIDOSIS 2 0.0488
4 PREALBUMIN INCREASED 1 0.0455
5 VITAMIN A DECREASED 5 0.0323
6 GRANULAR CELL TUMOUR 1 0.0217
7 TUBERCULIN TEST 1 0.0204
8 AMYLOID ARTHROPATHY 1 0.0143
9 GLOMERULAR FILTRATION RATE 1 0.0137
See all enriched reactions for Transthyretin-directed RNA Interaction [EPC]